In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.
Nicosia D., Federico A., Vigna I., Iozzo P., Misseri G., Cortegiani A. (2019). Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy. CLINICAL CASE REPORTS, 7(4), 665-667 [10.1002/ccr3.2061].
Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
Nicosia D.;Iozzo P.;Misseri G.;Cortegiani A.
2019-01-01
Abstract
In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ccr3.2061.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
239.52 kB
Formato
Adobe PDF
|
239.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
